NTRB Stock Summary and Trading Ideas (Nutriband | NASDAQ:NTRB)

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Nutriband trades on the NASDAQ stock market under the symbol NTRB.

As of June 5, 2026, NTRB stock price was flat at $3.58 with 3,908 million shares trading.

NTRB has a market cap of $43.52 million. This is considered a Sub-Micro Cap stock.

Last quarter Nutriband reported $400,709 in Revenue and -$.04 earnings per share. This fell short of revenue expectation by $-364,291 and exceeded earnings estimates by $1.85.

In the last 3 years, NTRB traded as high as $11.78 and as low as $1.53.

The top ETF exchange traded funds that NTRB belongs to (by Net Assets): VTI, VXF, IWC.

NTRB has underperformed the market in the last year with a return of -56.2%, while the SPY ETF gained +25.0%. In the last 3 month period, NTRB fell short of the market, returning -14.8%, while SPY returned +7.9%. However, in the most recent 2 weeks NTRB has outperformed the stock market by returning +2.6%, while SPY returned -0.7%.

NTRB support price is $3.40 and resistance is $3.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NTRB shares will trade within this expected range on the day.